Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Cipla
Moodys
Johnson and Johnson
US Army
Queensland Health

Generated: August 21, 2019

DrugPatentWatch Database Preview

Litigation Details for DIK DRUG COMPANY v. ALTANA PHARMA AG (D.N.J. 2007)

  Try a free trial


See Plans and Pricing

« Back to Dashboard

DIK DRUG COMPANY v. ALTANA PHARMA AG (D.N.J. 2007)

Docket   Try a Free Trial Date Filed 2007-12-06
Court District Court, D. New Jersey Date Terminated
Cause 28:1331 Fed. Question: Anti-trust Assigned To Jose L. Linares
Jury Demand Plaintiff Referred To Claire Claudia Cecchi
Parties ALTANA INC.; ALTANA PHARMA AG; ALTANA PHARMA US, INC.; DIK DRUG COMPANY; JAMES T. FAWCETT; KING DRUG COMPANY OF FLORENCE, INC.; NYCOMED S.C.A. SICAR; NYCOMED US INC.; PAINTERS DISTRICT COUNSEL NO. 30 HEALTH & WELFARE FUND; WYETH; WYETH PHARMACEUTICALS INC.; WYETH PHARMACEUTICALS, INC.
Patents 4,255,431; 4,758,579; 5,997,903
Attorneys JENNIFER C. CRITCHLEY; PETER S. PEARLMAN; THEODORE M. LIEVERMAN; WILLIAM H. GRAHAM
Firms Connell, Foley; Spector Roseman Kodroff
Link to Docket External link to docket
Small Molecule Drugs cited in DIK DRUG COMPANY v. ALTANA PHARMA AG
The small molecule drugs covered by the patents cited in this case are   Try a Free Trial ,   Try a Free Trial ,   Try a Free Trial , and   Try a Free Trial .

Details for DIK DRUG COMPANY v. ALTANA PHARMA AG (D.N.J. 2007)

Date Filed Document No. Description Snippet Link To Document
2007-12-06 1 either the ‘51 8 Patent or USPN 4,560,693 in view of USPN 4,255,431 (“the ‘431 Patent”), which teaches…are sometimes protected by a patent or patents, which provide the patent owner with the exclusive right… the patent or patents involved, plus any extensions Pursuant to 21 U.S.C. § 355(b)(1), a patent holder…filed patent information with the FDA (a “paragraph l certification”); (2) the patent or patents have … is able to obtain a patent from the Patent and Trademark Office, list the patent in the Orange Book and External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
Deloitte
AstraZeneca
Baxter
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.